Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin premedication for sedation in cataract surgery
IRCT20160307026950N45Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in cataract comparing Melatonin with Placebo (2 arms). Primary endpoint: intensity of pain. Started Sep 2022; status: completed.
02
Drugs
melatonin
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20160307026950N45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N45.